Revision history of "Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma" (Q33358646)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2023

30 November 2021

11 October 2021

24 December 2019

21 August 2019

  • curprev 10:4210:42, 21 August 2019 ԱշբոտՏՆՂ talk contribs 44,980 bytes +220 Updated Item: hy:description:2004 թվականի հունվարին հրատարակված գիտական հոդված, hyw:description:2004 թուականի Յունուարին հրատարակուած գիտական յօդուած undo (restore)

14 August 2019

13 August 2019

12 August 2019

25 April 2019

18 April 2019

4 March 2019

  • curprev 08:1308:13, 4 March 2019 Emijrpbot talk contribs 43,218 bytes +4,825 Updated Item: BOT - Adding descriptions (57 languages): ast, bg, bn, ca, cs, da, de, el, eo, es, et, fa, fi, fr, gl, he, hu, hy, it, ja, ka, ko, lt, nan, nb, nl, nn, oc, pl, pt, pt-br, ro, ru, sk, sq, sr, sr-ec, sr-el, sv, tg, tg-cyrl, th, tl, tr, ur, vi, wuu, yue, zh, zh-cn, zh-hans, zh-hant, zh-hk, zh-mo, zh-my, zh-sg, zh-tw undo (restore)

4 January 2019

20 August 2018

21 December 2017

18 October 2017

26 July 2017